Nguyen Trong Nguyen1, Ilwoo Park2,3, Ngoc Luu Do2, Tien Anh Nguyen2, Sang Heon Suh 4, Eun Hui Bae4, and Sang Soo Shin2
1Department of Biomedical Science, Chonnam National University, Gwangju, Korea, Republic of, 2Department of Radiology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of, 3Department of Artificial Intelligence Convergence, Chonnam National University, Gwangju, Korea, Republic of, 4Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea, Republic of
Synopsis
Alport Syndrome (AS) is an inherited kidney disease with progressive kidney failure. We investigate the potential of hyperpolarized 13C MRI to be used as an non-invasive technique for detecting early abnormal changes in renal metabolism. Hyperpolarized [1-13C]pyruvate imaging was applied to AS and wild-type mice at 4- and 7-week-old. Normalized Lactate in AS model was significantly lower at 7-week compared to 4-week. This abnormal renal metabolism in AS mice was consistent with PEPCK analysis, which showed increased expression level as the disease progressed. We demonstrated the feasibility of this technique for assessing early renal function in mouse model of AS.
Purpose
Alport Syndrome (AS) is a genetic
disorder that is characterized by progressive loss of kidney function. Although
the evaluation of early changes in renal function are important for therapy, patients
with this condition are often diagnosed too late and noninvasive assessment of
renal function in early stage is still challenging. Hyperpolarized (HP) 13C
MRI is an emerging technique that enables noninvasive, real-time measurement of
in vivo metabolism [1]. This study aimed to investigate the feasibility of
using this technique for assessing early renal metabolism in mouse model of AS. Method and Material
Eight male Col4a3-/- were
included as a model of AS and eight male wild-type as control. All imaging data
were obtained using a GE clinical 3T scanner with a 13C/1H
dual mouse coil (RAPID biomedical, Rimpar, Germany). 18L of [1-13C]pyruvate (with 1.5mM gadolinium) was
polarized using a HyperSense DNP polarizer (Oxford Instruments, Abingdon, UK)
[1]. Compressed sensing 3D 13C magnetic resonance spectroscopic
imaging (MRSI) data [2] were acquired after the administration of HP [1-13C]-pyruvate
at 4- and 7-week-old time point from each animal. For quantitative assessment
of in vivo metabolism, the signals of pyruvate and its metabolic product,
lactate, were normalized by the maximum vascular total carbon signal (nLac and
nPyr, respectively). The
temporal changes in metabolite level were compared for each group using a
paired t-test. The metabolite parameters in kidney (voxels containing greater
than 90% kidney in volume) were compared between the two groups at each time
point using an unpaired t-test. At each time points, phosphoenolpyruvate
carboxykinase (PEPCK) expression levels were measured in kidney tissue of AS
and control mice using quantitative polymerase chain reaction (PCR). Result and Discussion
Figure
1 illustrates representative 3D 13C MRSI data from a AS mouse. The
sagittal and axial image of the mouse show the 5.4 mm slice that the data were
acquired from and the spatially-resolved 13C spectroscopic imaging
voxels overlaid on top of the axial image. The green and red voxels correspond
to the kidney and vascular voxels used for metabolite quantification. The 13C
MRSI data with a 22 mm in-plane resolution produced lactate
and pyruvate signals with substantial sensitivity.
nLac
of the knock-out mice significantly reduced from 0.20±0.04 at 4-week-old to
0.17±0.04 at 7-week-old (p=0.027; Fig
2A). The wild-type mice showed a significant increase of nPyr from 0.43±0.08 at
4-week-old to 0.52±0.06 at 7-week-old (p=0.0039;
Fig 2B). For the comparison between the two groups, nPyr of knock-out mice was
significantly higher than that of wild-type mice at 4-week-old (0.53±0.08 vs
0.45±0.08, respectively, p=0.040; Fig3).
nLac of knock-out mice was smaller than that of wild-type at 7-week-old
(0.17±0.04 vs 0.21±0.05, respectively, p=0.064;
Fig3).
PEPCK
expression level of knock-out mice in 7-week-old was significantly higher than
that of 4 week-old knock out mice. PEPCK is known as the rate-limiting enzyme
of gluconeogenesis and PEPCK expression is widely used for marker of
gluconeogenesis [3]. The increased level of PEPCK expression of AS mice at 7-week-old
compared to at 4-week-old was consistent with our imaging finding where the
level of nLac was reduced in AS mice as the disease progresses. In contrast, the
control group showed a similar level of PEPCK expression at 4 and 7 week. Conclusion
The noninvasive assessment of early
renal functional changes in AS is important for diagnosis as well as for identifying
proper treatment strategy. We demonstrated the potential of HP 13C
MRI for early monitoring of metabolic changes in AS. AS mice presented an early
metabolic abnormality that prohibited pyruvate-to-lactate conversion, which was
consistent with the increased level of PEPCK expression as the disease
progresses. The results from this study warrant further investigation of
underlying mechanism that corresponds to the observed metabolic changes in the
early stage of AS.Acknowledgements
This study was supported by the
Ministry of Education, Republic of Korea (2019R1I1A3A01059201) and the Korea
Health Technology R&D Project through the Korea Health Industry Development
Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of
Korea (HR20C0021).References
1. Ardenkjaer-Larsen JH, et al. Increase
in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl
Acad Sci USA. 2003;100(18):10158-63.
2. Park I, et al. Evaluation of
heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft
model using compressed sensing hyperpolarized 3D 13C magnetic resonance
spectroscopic imaging. Magn Reson Med. 2012;70(1):33-9.
3. Chakravarty K, et. al. Factors that
control the tissue-specific transcription of the gene for phosphoenolpyruvate
carboxykinase-C. Crit Rev Biochem Mol Biol 2005;40:129–154.